Resistance mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors in non‐small cell lung cancer patients: A meta‐analysis

BACKGROUND: Differences in the resistance mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors in patients with non‐small cell lung cancer (NSCLC) harboring epidermal growth factor receptor mutations are unknown. This meta‐analysis aimed to clarify the differences in resistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Nobuaki, Katakura, Seigo, Kamimaki, Chisato, Somekawa, Kohei, Fukuda, Nobuhiko, Tanaka, Katsushi, Watanabe, Keisuke, Horita, Nobuyuki, Hara, Yu, Piao, Hongmei, Kaneko, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017253/
https://www.ncbi.nlm.nih.gov/pubmed/33565276
http://dx.doi.org/10.1111/1759-7714.13878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017253/
https://www.ncbi.nlm.nih.gov/pubmed/33565276
http://dx.doi.org/10.1111/1759-7714.13878

Ejemplares similares